Table of Contents Executive Summary 1 Industry Overview of Human cytomegalovirus 65 kDa Phosphoprotein 1.1 Definition of Human cytomegalovirus 65 kDa Phosphoprotein 1.2 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Type 1.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Comparison by Types (2014-2025) 1.2.2 HB-101 1.2.3 CyMVectin 1.2.4 ASP-0113 1.2.5 PepVax 1.2.6 Others 1.3 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Applications 1.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Comparison by Applications (2014-2025) 1.3.2 Brain Tumor 1.3.3 Hemotaological Tumor 1.3.4 Kidney Transplant Rejection 1.3.5 Liver Transplant Rejection 1.3.6 Others 1.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Overall Market 1.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (2014-2025) 1.4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Production (2014-2025) 1.4.3 North America Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 1.4.4 Europe Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 1.4.5 China Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 1.4.6 Japan Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 1.4.7 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 1.4.8 India Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Human cytomegalovirus 65 kDa Phosphoprotein 2.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein 2.4 Industry Chain Structure of Human cytomegalovirus 65 kDa Phosphoprotein 3 Development and Manufacturing Plants Analysis of Human cytomegalovirus 65 kDa Phosphoprotein 3.1 Capacity and Commercial Production Date 3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Human cytomegalovirus 65 kDa Phosphoprotein 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Human cytomegalovirus 65 kDa Phosphoprotein Production and Capacity Analysis 4.2 Human cytomegalovirus 65 kDa Phosphoprotein Revenue Analysis 4.3 Human cytomegalovirus 65 kDa Phosphoprotein Price Analysis 4.4 Market Concentration Degree 5 Human cytomegalovirus 65 kDa Phosphoprotein Regional Market Analysis 5.1 Human cytomegalovirus 65 kDa Phosphoprotein Production by Regions 5.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production by Regions 5.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Regions 5.2 Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Regions 5.3 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.3.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Production 5.3.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 5.4 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.4.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Production 5.4.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 5.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production 5.5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 5.6 Japan Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.6.1 Japan Human cytomegalovirus 65 kDa Phosphoprotein Production 5.6.2 Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 5.7 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.7.1 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Production 5.7.2 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 5.8 India Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis 5.8.1 India Human cytomegalovirus 65 kDa Phosphoprotein Production 5.8.2 India Human cytomegalovirus 65 kDa Phosphoprotein Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Human cytomegalovirus 65 kDa Phosphoprotein Import and Export 6 Human cytomegalovirus 65 kDa Phosphoprotein Segment Market Analysis (by Type) 6.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production by Type 6.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type 6.3 Human cytomegalovirus 65 kDa Phosphoprotein Price by Type 7 Human cytomegalovirus 65 kDa Phosphoprotein Segment Market Analysis (by Application) 7.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Application 7.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Share by Application (2014-2019) 8 Human cytomegalovirus 65 kDa Phosphoprotein Major Manufacturers Analysis 8.1 Astellas Pharma Inc 8.1.1 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.1.2 Astellas Pharma Inc Product Introduction, Application and Specification 8.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Hookipa Biotech AG 8.2.1 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.2.2 Hookipa Biotech AG Product Introduction, Application and Specification 8.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Immunomic Therapeutics Inc 8.3.1 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.3.2 Immunomic Therapeutics Inc Product Introduction, Application and Specification 8.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Vakzine Projekt Management GmbH 8.4.1 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.4.2 Vakzine Projekt Management GmbH Product Introduction, Application and Specification 8.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Vaximm AG 8.5.1 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.5.2 Vaximm AG Product Introduction, Application and Specification 8.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 VBI Vaccines Inc 8.6.1 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.6.2 VBI Vaccines Inc Product Introduction, Application and Specification 8.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Vical Inc 8.7.1 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served 8.7.2 Vical Inc Product Introduction, Application and Specification 8.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of Human cytomegalovirus 65 kDa Phosphoprotein Market 9.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Trend Analysis 9.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Volume and Value) Forecast 2019-2025 9.2 Human cytomegalovirus 65 kDa Phosphoprotein Regional Market Trend 9.2.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.2.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.2.3 China Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.2.4 Japan Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.2.5 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.2.6 India Human cytomegalovirus 65 kDa Phosphoprotein Forecast 2019-2025 9.3 Human cytomegalovirus 65 kDa Phosphoprotein Market Trend (Product Type) 9.4 Human cytomegalovirus 65 kDa Phosphoprotein Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Human cytomegalovirus 65 kDa Phosphoprotein Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Human cytomegalovirus 65 kDa Phosphoprotein Table Global Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Types in 2018 Figure HB-101 Product Picture Figure CyMVectin Product Picture Figure ASP-0113 Product Picture Figure PepVax Product Picture Figure Others Product Picture Table Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Share by Applications in 2018 Figure Brain Tumor Figure Hemotaological Tumor Figure Kidney Transplant Rejection Figure Liver Transplant Rejection Figure Others Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) (2014-2025) Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs) (2014-2025) Figure North America Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Figure India Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) (2014-2025) Table Human cytomegalovirus 65 kDa Phosphoprotein Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Human cytomegalovirus 65 kDa Phosphoprotein in 2018 Figure Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein Figure Industry Chain Structure of Human cytomegalovirus 65 kDa Phosphoprotein Table Capacity and Commercial Production Date of Key Manufacturers Table Global Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Plants Distribution Table Human cytomegalovirus 65 kDa Phosphoprotein Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Human cytomegalovirus 65 kDa Phosphoprotein Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs) of Major Manufacturers (2014-2019) Table Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share of Major Manufacturers (2014-2019) Figure Human cytomegalovirus 65 kDa Phosphoprotein Production Share by Manufacturers in 2018 Table Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million US$) of Major Manufacturers (2014-2019) Table Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share of Major Manufacturers (2014-2019) Figure Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Manufacturers in 2018 Table Human cytomegalovirus 65 kDa Phosphoprotein Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Human cytomegalovirus 65 kDa Phosphoprotein Production by Regions 2014-2019 (K Pcs) Table Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Regions 2014-2019 Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Regions in 2018 Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Regions 2014-2019 (Million USD) Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions 2014-2019 Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions in 2018 Table Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Regions 2014-2019 (K Pcs) Table Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Share by Regions 2014-2019 Figure North America Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table North America Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure China Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table China Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure India Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate 2014-2019 (K Pcs) Figure India Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2014-2019 (Million USD) Table India Human cytomegalovirus 65 kDa Phosphoprotein Production, Consumption Import and Export (K Pcs) Figure Global Consumption Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application (2014-2019) Figure Global Value (Consumption) Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application (2014-2019) Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019) Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share (2014-2019) Figure Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (2014-2019) Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Main Business and Markets Served Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Human cytomegalovirus 65 kDa Phosphoprotein by Type (2019-2025) Table Global Consumption (K Pcs) of Human cytomegalovirus 65 kDa Phosphoprotein by Application (2019-2025) Table Human cytomegalovirus 65 kDa Phosphoprotein Distributors List Table Human cytomegalovirus 65 kDa Phosphoprotein Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Astellas Pharma Inc Hookipa Biotech AG Immunomic Therapeutics Inc Vakzine Projekt Management GmbH Vaximm AG VBI Vaccines Inc Vical Inc